Fat Loss & Metabolic Health
What Do Clinical Trials Indicate About the Fat-Burning Potential of AOD-9604 Peptide?
The question in the title carries a quiet assumption worth surfacing before we examine a single data point: it presumes that clinical…
Does Semaglutide Provide a Sustainable Solution for Long-Term Weight Loss?
Semaglutide keeps weight off for as long as you keep taking it, and largely stops working when you stop. In the STEP…
How Does Tirzepatide Improve Fat Loss and Insulin Sensitivity in Clinical Research?
In SURMOUNT-1, tirzepatide at 15 mg weekly reduced body weight by 20.9% over 72 weeks, against 3.1% on placebo — among the…
Can Scientific Research Validate Cagrilintide’s Role in Appetite Regulation?
Short answer: yes on the narrow question, no on the broad one. Cagrilintide is a long-acting synthetic analog of amylin, the pancreatic…
Retatrutide and Cholesterol: What the Trials Measured
Retatrutide moves every lipid marker that defines atherogenic dyslipidemia in the right direction — and it has never been trialled as a…
What Do Studies Reveal About KLOW Peptides and Energy Metabolism?
The question in the title carries a quiet assumption that deserves to be examined before anything else: that “studies” have looked at…
Can Scientific Evaluation Uncover GLP-1 Signaling Mechanisms in Arterial Stiffness?
Short answer: no — not measurably. Research has revealed a great deal about how GLP-1 signalling could influence the vessel wall, but…
AOD-9604 and Brain Health in Obesity: What Research Shows
The title of this article poses a question, and the honest answer has to be given up front, before any of the…
Does Current Evidence Support Tirzepatide as a Breakthrough Therapy For Type-2 Diabetes?
Few molecules in modern metabolic medicine have generated as much discussion as tirzepatide. Marketed as Mounjaro for glycemic control in type 2…
Does Current Research Support Cagrilintide’s Role in Lowering Stroke Risk?
No study has ever tested whether Cagrilintide lowers stroke risk. As of 2026 there is no completed trial with stroke as an…